Loading
Alcohol causes at least seven cancers and there is no safe threshold. Price, availability and cancer warning labels are the tools that work; most people still do not know alcohol causes cancer.
Alcohol is an IARC Group 1 carcinogen causally linked to cancers of the mouth, pharynx, larynx, oesophagus (squamous), liver, colorectum and female breast; the 2020 global estimate attributed about 741,000 new cancers (4% of all) to alcohol, with a measurable share from light and moderate drinking. Risk is dose-dependent with no threshold for breast cancer. Population interventions with the best evidence are minimum unit pricing (Scotland 2018: alcohol-specific deaths fell about 13%), taxation, restrictions on availability and marketing, and labelling. Ireland's mandatory cancer warning on alcohol labels (legislated 2023, implementation deferred to 2028) and the 2025 US Surgeon General's advisory calling for cancer warnings mark a shift, opposed by industry. Awareness that alcohol causes cancer remains below 50% in most surveys. After a cancer diagnosis, continued drinking is associated with second primaries in head and neck cancer and possibly recurrence in breast cancer, but reduction trials in survivors are few.
Ethanol and its metabolite acetaldehyde are genotoxic, raise oestrogen levels, and act as a solvent for other carcinogens (especially tobacco); population-level price and availability policies reduce consumption more reliably than individual advice.
Query for this technology: (TITLE:"Alcohol reduction, pricing and cancer warning labels" OR ABSTRACT:"Alcohol reduction, pricing and cancer warning labels") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Alcohol reduction, pricing and cancer warning labels, not a curated reading list.
Shares Cancer warnings on alcohol labels, evaluated as a natural experiment, International Agency for Research on Cancer (IARC / WHO), Misinformation and unproven therapies, Prevention we already have is not deployed.
Shares Hypopharyngeal cancer, Laryngeal and hypopharyngeal cancer, Oral tongue and floor of mouth cancer, Oesophageal squamous cell carcinoma.
Shares International Agency for Research on Cancer (IARC / WHO), Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, Prevention we already have is not deployed, Hepatocellular carcinoma.
Shares Hypopharyngeal cancer, Laryngeal and hypopharyngeal cancer, HPV-negative head and neck squamous cell carcinoma (including HPV-negative oropharyngeal cancer), Head and neck squamous cell carcinoma.
Shares Chemoprevention & risk-reducing surgery, Diet, exercise and lifestyle roadmap: causes established → interventions that disappointed → exercise proven as treatment, Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, Prevention we already have is not deployed.
Shares Diet, exercise and lifestyle roadmap: causes established → interventions that disappointed → exercise proven as treatment, Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, Misinformation and unproven therapies, Prevention we already have is not deployed.
Shares Chemoprevention & risk-reducing surgery, Diet, exercise and lifestyle roadmap: causes established → interventions that disappointed → exercise proven as treatment, Cancer prevention roadmap: tobacco control and vaccines → biomarker-guided chemoprevention → interception in carriers, Prevention we already have is not deployed.
Shares Diet, exercise and lifestyle roadmap: causes established → interventions that disappointed → exercise proven as treatment, Prevention we already have is not deployed, Oesophageal cancer, Hepatocellular carcinoma.